---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-016181"
form_type: "8-K"
ticker: "PTPI"
cik: "0001815903"
company_name: "Petros Pharmaceuticals, Inc."
filed_at: "2025-02-21T23:59:59+00:00"
generated_at: "2026-05-26T07:08:29.217552+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Petros Pharmaceuticals Prices $9.6 Million Public Offering of Common Stock and Warrants

## Summary
- Petros Pharmaceuticals entered securities purchase agreement for 13,950,012 units and 26,049,988 pre-funded units at $0.24 and $0.2399 per unit.
- Offering closed on February 19, 2025, with gross proceeds of approximately $9.6 million.
- Each unit includes one share (or pre-funded warrant), one Series A warrant (0.25 share) and one Series B warrant (1 share) at $0.48 exercise price.
- Warrants exercisable only upon stockholder approval; pre-funded warrants immediately exercisable at $0.0001 per share.
- Company granted 1,000,000, 300,000, 150,000, 450,000, 150,000, and 150,000 restricted shares to directors Silverman, Bernstein, Walker, Boctor, Arnold, and Weinstein.

## SEC filing metadata
- accession: 0001104659-25-016181
- form_type: 8-K
- ticker: PTPI
- cik: 0001815903
- company_name: Petros Pharmaceuticals, Inc.
- filed_at: 2025-02-21T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1815903/000110465925016181/0001104659-25-016181-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1815903/000110465925016181/tm257154d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-016181
- JSON: https://secwatch.observer/filing/0001104659-25-016181.json
- Plain text: https://secwatch.observer/filing/0001104659-25-016181.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.